SARS臨床症狀概要\(試用版\)

Size: px

Start display at page:

Download "SARS臨床症狀概要\(試用版\)"

婆尹
7 years ago
Views:

1 SARS 1

2 .SARS 4.SARS 5.SARS 6.SARS 7.SARS 8.SARS 9.SARS 10. SARS 12.SARS 14.SARS 16. SARS 18. SARS 19 () 23 () 24 () SARS 25. SARS 26 () 29 () 30 2

3 . SARS 33 () 36 () 37 () SARS 45. SARS 46.SARS 50 Suspect SARS Patients Screening and Treatment Special Sheet SARS SARS

4 SARS ( ) 4

5 SARS ( ) (Severe Acute Respiratory SyndromeSARS) SARS 15 SARS > lower respiratory phase 10-20% SARS probable suspect 3% X respiratory phase focal patchy SARS X consolidation Lymphopenia 酶 creatinine phosphokinase 3000 酶 hepatic transaminase 2 6 oseltamivir ribavirin ribavirin MMWR 21 Mar,

phase focal patchy SARS X consolidation Lymphopenia 酶 creatinine phosphokinase

6 SARS ( ) WHO SARS Suspect SARS SARS SARS SARS WHO Probable SARS X Respiratory Distress Syndrome -- MMWR 21 Mar,

7 SARS ( ) Suspect SARS SARS 10 X X X Probable SARS SARS 1. cold agglutinins Weli-Felix reaction Widal s test 2. 10cc 3. 10cc X MMWR 21 Mar,

8 SARS ( ) 1 SARS 2SARS N95 3 N95 4 SARS SARS SARS.... WHO barrier nursing SARS N95 SARS N95 N95 MMWR 21 Mar,

9 SARS ( ) N % (5% 100 ) 0.05% 30 ( ) N95 9

10 SARS ( ) 0.05% 5% % ( ) Portable X 0.05% ( ) ( 1/ CC 5% 1CC)30 10

11 0.05% % 30 11

12 SARS ( ) N95 oximeter oximeter 12

13 X N95 MMWR 21 Mar,

14 SARS ( ) SARS 酶 (creatinine phosphokinase) 4. X SARS 38 X X 2 14

15 SARS MMWR 21 Mar,

16 SARS ( ) SARS % * * * * 1. * * 16

17 * * * MMWR 21 Mar,

18 SARS 18

19 SARS : 1.fever38 2 Respiratory symptoms ( ) 3 10 SARS 10 ( ) WHO N95 10 ( ) ( ) ( )!! N95 19

20 N95 ( ) ( ) ( ) 8. N ( )!! 0.05% (5% 100 ) 0.05% % ( 1/ % 1 ) 30 20

21 N95 x-ray ( ) N95 N95 N95 CBC+DCCK LFTBUNCre - CRP CXR Suspect SARS case screening special sheet ( 1) medical problem ( ) (CXR pneumonia ) community acquired 21

22 pneumonia ( 2) 0.05% 10 ( ) ( 22

23 N95 ( ) ( ) 23

24 1. 2. (N95 ) N95 24

25 SARS X X SARS N95 X 25

26 SARS SARS ( ) ( 0.05% ) 0.05% P100 ( )N 95 N 95 ( P100 ) (0.05% ) ( ) ( )5% ( ) 26

27 N95 N95 ( N95 ) N95 S P O 2 S P O 2 95% ( ) 0.05% 10 ( ) ( ) 27

28 ( ) 0.05% (5% 100 ) 0.05% ( 1/ CC 5% 1CC)10 28

29 ( ) N95 29

30 ()

31 ( ) ( ) 0.51 ( P100 ) ( ) ( ) ( ) ( ) () 31

32 () ( ) N95 P100 ( ) 32

33 SARS ( ) N 100 N 95 (0.05% ) ( )5% ( ) 5% 33

34 ( ) 0.05% 10 ( ) ( 4. ( ) % (5% 100 ) 0.05% 34

35 ( 1/ CC 5% 1CC)

36 N95 ( ) ( ) 36

37 (N95 ) N95 37

38 () 38

39 () (N95 ) N95 39

40 () N

41 () (0.05%), 0.05% (0.05%) 41

42 () N95 (0.05%), ( ) ( ) 42

43 () (0.05%) 0.05% N95 N95 43

44 44

45 SARS 0.05% N95 45

46 () SARS ( ) P100 ( )N 95 N 95 (0.05% ) ( ) ( ) ( ) 46

47 ()

48 4. 5. N95 N95 ( N95 ) N ( ) 0.05% 10 ( ) ( 4. ( ) % (5% 100 ) 0.05%

49 ( 1/ CC 5% 1CC)

50 SARS 1. http// 2. http// 3. http// 4. http// 5. MEDSCAPEhttp// 6. : ( ) 50

51 Suspect SARS Patients Screening and Treatment Special Sheet 1. History Screening: Measured temperature Respiratory symptoms: AND (>38) AND ( ) cough sputum dyspnea headache muscle ache malaise loss of appetite diarrhea confusion rash Travel Hx: OR Period: 200_~ 200 Area: Close contact Hx with a SARS-like p t Period: 200 ~ 200 Patient name: Admitted at ( ) 2. Diagnostic Evaluations: SpO2, CBC/DC, CXR, CRP 3. Criteria for Probability: Probable case: Hx(+) CXR(+) Suspect case: only Hx(+) 51

53 92 SARS 1.14 ( ) : 92 ~ SARS SARS 92 ~ 92 / /

54 92 SARS 1.14 ( ) : 92 ~ SARS SARS 92 ~

55 SARS. SARS N95 () 10 (1 ) N95 ( ) N95 (100cc 5% 1cc) % SARS BBcall ( ) 0.05% SARS N95. ( ) 55

56 3 3 SARS SARS 14 SARS 56

57 10-14 SARS ( ) N95 ( )

58 SARS N

63 * *

66 * 66

美國國務院已下令非必要外交人員家屬撤離沙國, 同時呼應五月一日發出的旅遊警訊, 建議在沙國的美國民間人士考慮離境, 美國人非必要暫勿前往沙國美國官員事先已警告,

美國國務院已下令非必要外交人員家屬撤離沙國, 同時呼應五月一日發出的旅遊警訊, 建議在沙國的美國民間人士考慮離境, 美國人非必要暫勿前往沙國美國官員事先已警告, 層出不窮的恐怖攻擊國際要聞評析陳斯劫近二十天來, 恐怖攻擊迭有發生, 令舉世為之惶惑不安, 死傷人數總共逾五百人先是一輛載有爆炸物的卡車於上 ( 五 ) 月十二日在車臣北部的佐納曼斯柯耶衝進一個聯邦政府及地方政府辦公區